GL stock forecast: what analysts expect
Wall Street analysts covering Globe Life Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $193.91 — +9.0% versus the last price of $177.91. Targets reflect analyst opinion, not a guarantee.
GL historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in GL.
GL annual returns by year
Congress trading in GL
2 members of Congress have disclosed trading GL — 0 purchases and 2 sales worth an estimated $16,000. Most recent disclosure: Jul 10, 2025.
Insider activity in GL
GL's own executives and directors have made 0 open-market purchases ($0) and 33 sales ($40.8M) in the last 90 days, per SEC Form 4 filings. Most recent: Aug 7, 2026.
| Aug 7, 2026 | Mitchell Robert Brian | EVP, General Counsel and CRO | Sell | $2.1M |
| Aug 7, 2026 | Mitchell Robert Brian | EVP, General Counsel and CRO | Sell | $1.9M |
| Aug 7, 2026 | Mitchell Robert Brian | EVP, General Counsel and CRO | Sell | $187,892 |
| Jul 31, 2026 | Darden James Matthew | Co-Chairman & CEO | Sell | $9.0M |
| Jul 31, 2026 | Darden James Matthew | Co-Chairman & CEO | Sell | $73,343 |
About Globe Life Inc.
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
GL Key Statistics
GL in plain English
- P/E ratio (12.0) — how many dollars you pay for each $1 of GL's yearly profit. That's on the low side, which can mean it's cheap — or that the market is worried.
- ROE (20.94%) — how efficiently the company turns shareholders' money into profit. Above ~20% is considered strong.
- Profit margin (19.58%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (0.73%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
GL stock: frequently asked questions
What is Globe Life Inc.'s stock price today?
Globe Life Inc. (GL) last traded at $177.91 on the NYSE. Over the past 52 weeks the stock has traded between $127.85 and $191.55.
Is GL stock a buy or a sell?
Wall Street analysts' consensus rating on GL is "Buy", with an average 12-month price target of $193.91 — about +9.0% versus the current price of $177.91. Analyst targets are opinions, not guarantees; always do your own research.
How much would $1,000 invested in GL 10 years ago be worth today?
A $1,000 investment in Globe Life Inc. made 10 years ago would be worth about $2,988 today (dividends reinvested) — a total return of 199%, or 11.6% per year.
Does GL pay a dividend?
Yes. Globe Life Inc. currently pays a dividend yielding about 0.73% per year at today's share price.
What is GL's P/E ratio?
GL trades at a trailing price-to-earnings ratio of 12.0, and 10.8 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade GL stock?
Yes — 2 members of Congress have disclosed trades in GL under the STOCK Act, totaling 0 purchases and 2 sales worth an estimated $16,000.
What is Globe Life Inc.'s ticker symbol?
Globe Life Inc. trades under the ticker symbol GL on the NYSE.
Compare GL with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.